目的:许多研究报道了辐射敏感蛋白51(RAD51)在各种类型的癌症中的过表达。然而,RAD51基因型在肺癌中的作用尚不清楚.这项研究旨在评估常见变异RAD51rs1801320(G-135C)基因型对台湾肺癌风险的影响。
方法:在包含358名肺癌患者和716名年龄和性别匹配的健康对照的队列中,研究了RAD51rs1801320基因型对肺癌风险的贡献。利用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法。
结果:分析显示,在对照组中,GG的百分比,CG,RAD51rs1801320的CC基因型为73.2%,24.3%,和2.5%,分别。在肺癌患者中,这些百分比是71.0%,25.1%,和3.9%,分别(趋势p=0.4075)。等位基因频率分布显示RAD51rs1801320的C等位基因与肺癌风险测定之间没有显着关联(p=0.2987)。具体来说,RAD51rs1801320CC基因型与男性[调整比值比(aOR)=2.28,95%置信区间(95CI)=1.03-4.87]和吸烟者(aOR=2.93,95CI=1.23-5.87)的肺癌风险升高相关,但不是女性和不吸烟者。
结论:RAD51rs1801320CC基因型被确定为男性和吸烟者肺癌风险升高的危险因素。该基因型可作为DNA水平的分子生物标志物,用于台湾肺癌的早期检测和预测。
OBJECTIVE: Numerous studies have reported the over-expression of the radiation-sensitive protein 51 (RAD51) in various types of cancer. However, the role of RAD51 genotypes in lung cancer remains largely unknown. This study aimed to assess the impact of the common variant RAD51 rs1801320 (G-135C) genotypes on the risk of lung cancer in Taiwan.
METHODS: The contribution of RAD51 rs1801320 genotypes to lung cancer risk was investigated in a cohort comprising 358 lung cancer patients and 716 age- and sex-matched healthy controls, utilizing polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methodology.
RESULTS: The analysis revealed that among the control subjects, the percentages of GG, CG, and CC genotypes of RAD51 rs1801320 were 73.2%, 24.3%, and 2.5%, respectively. Among the lung cancer patients, these percentages were 71.0%, 25.1%, and 3.9%, respectively (p for trend=0.4075). Allelic frequency distributions showed no significant association between the C allele of RAD51 rs1801320 and lung cancer risk determination (p=0.2987). Specifically, the RAD51 rs1801320 CC genotypes were associated with an elevated risk of lung cancer among males [adjusted odds ratio (aOR)=2.28, 95% confidence interval (95%CI)=1.03-4.87] and smokers (aOR=2.93, 95%CI=1.23-5.87), but not among females and non-smokers.
CONCLUSIONS: The RAD51 rs1801320 CC genotype was identified as a risk factor for elevated lung cancer risk in males and smokers. This genotype may serve as a molecular biomarker at the DNA level for early detection and prediction of lung cancer in Taiwan.